v3.26.1
ORGANIZATION (Tables)
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF CHANGES OF EQUITY TO THE IMPACT OF REVERSE STOCK SPLIT

The following table illustrates changes in equity, as previously reported prior to, and as adjusted subsequent to, the impact of the Reverse Stock Split retroactively adjusted for the periods presented:

 

  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
   March 31, 2025 
  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
             
Common stock - shares   8,219,844,297    (8,218,200,327)   1,643,970 
Common stock - amount  $8,219,844   $(8,218,200)  $1,644 
Common stock to be issued- shares   637,755    (637,627)   128 
Common stock to be issued- amount  $638   $(638)  $- 
Additional paid-in capital  $197,439,693   $8,218,838   $205,658,531 

 

  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
   December 31, 2024 
   As Previously Reported   Impact of Reverse Stock Split   As Revised 
             
Common stock - shares   7,086,021,742    (7,084,604,538)   1,417,204 
Common stock - amount  $7,086,021   $(7,084,604)  $1,417 
Common stock to be issued - shares   637,755    (637,627)   128 
Common stock to be issued - amount  $638   $(638)  $- 
Additional paid-in capital  $198,312,711   $7,085,242   $205,397,953 
SCHEDULE OF CHANGE IN LOSS PER SHARE AND WEIGHTED AVERAGE SHARES

The following table illustrates changes in loss per share and weighted average shares outstanding, as previously reported prior to, and as adjusted subsequent to, the impact of the Reverse Stock Split retroactively adjusted for periods presented:

 

  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
   Three Months ended March 31, 2025 
  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
Loss attributable to common shareholders  $(1,557,171)  $   $(1,557,171)
Weighted average shares used to compute basic and diluted EPS   7,609,003,782    (7,607,481,981)   1,521,801 

Loss from continuing operations per share - basic and diluted

  $(0.00)  $(1.02)  $(1.02)

Income from discontinued operations per share - basic and diluted

  $0.00   $-   $0.00 
Loss per share - basic and diluted  $(0.00)   $(1.02)  $(1.02)
SCHEDULE OF COMMON STOCK EXERCISABLE OR ISSUABLE FROM OUTSTANDING STOCK WARRANTS

The following shares of common stock exercisable or issuable from outstanding stock warrants and convertible instruments were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:

  

  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
   March 31, 2025 
  

As Previously

Reported

  

Impact of Reverse

Stock Split

   As Revised 
Unexercised common stock purchase warrants   732,024,518    (731,878,113)   146,405 
Convertible preferred stock   12,329,766,446    (12,327,300,493)   2,465,953 
Convertible notes payable   471,429,292    (471,335,006)   94,286 
Promissory notes payable   7,577,465,753    (7,575,950,260)   1,515,493